Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors.
Autor: | Leung CH; Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. duncanl@hkbu.edu.hk, Chan DS, Kwan MH, Cheng Z, Wong CY, Zhu GY, Fong WF, Ma DL |
---|---|
Jazyk: | angličtina |
Zdroj: | ChemMedChem [ChemMedChem] 2011 May 02; Vol. 6 (5), pp. 765-8. Date of Electronic Publication: 2011 Mar 01. |
DOI: | 10.1002/cmdc.201100016 |
Databáze: | MEDLINE |
Externí odkaz: |